PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Energy-efficiency Concerns Drive the Total Pumps Market in the European Pharmaceutical Industry Finds Frost & Sullivan - The European pharmaceutical industry has managed to remain insular to the economic crisis due to government-aided stimulus packages
Energy-efficiency Concerns Drive the Total Pumps Market in the European Pharmaceutical Industry Finds Frost & Sullivan

 

NewswireToday - /newswire/ - London, United Kingdom, 2010/11/11 - The European pharmaceutical industry has managed to remain insular to the economic crisis due to government-aided stimulus packages.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The demand for pumps in the European pharmaceutical industry is expected to increase because of certain re-initiated projects in the recovering economies. Product types including centrifugal, peristaltic and lobe pumps will have a significant rise in their revenue shares in the total market triggered by competitive factors like total cost of ownership and energy efficiency.

New analysis from Frost & Sullivan (industrialautomation.frost.com), Strategic Analysis of Pumps Market in the European Pharmaceutical Industry, finds that the total market earned revenues of $85.4 million in 2009 and estimates this to reach $102.0 million in 2016.

"Since end users are more concerned about life-cycle cost and energy efficiency while purchasing a product, manufacturers are impelled to focus on reducing costs," says Frost & Sullivan Research Analyst Ram Ravi. "Additionally, volatile energy prices coupled with regulatory pressure focused on improving standards is expected to drive the demand for products with low lifecycle cost and high energy efficiency."

The pharmaceutical industry is anticipated to provide considerable growth opportunities in the long term driven by regulations, patents and investments in biotechnology. The need for industry participants in Eastern Europe to comply with EU standards will provide opportunities for replacing, upgrading or servicing their products. This is expected to be a short-term driver to this market.

However, customers prefer a one-stop-shop solution and focus on procuring complete integrated solutions as against stand-alone pumps. Pump suppliers are not equipped to provide such complete integrated solutions.

"Transformation into solution providers would require suppliers to extend their product portfolio and knowledge to other product types," explains Ravi. "This would require investment in training and knowledge transfer for new segments as well as in strategic partnership or acquisition."

Manufacturers should enhance their product portfolio with a particular interest on pumps with energy efficiency and low life cycle cost. Greater attention on offering innovative and strategic services is expected to result in short-term benefits.

"Intelligent pumps and services offer long-term growth potential," concludes Ravi. "Increasing awareness about the advantages of intelligent pumps enhances the probability of long-term success."

If you are interested in more information on this study, please send an email to Joanna Lewandowska, Corporate Communications, at joanna.lewandowska[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.

Strategic Analysis of Pumps Market in the European Pharmaceutical Industry is part of the Industrial Automation & Process Control Growth Partnership Services programme, which also includes research in the following markets: Strategic Analysis of the World Centrifugal Pumps Market, Strategic Analysis of the European Positive Displacement Pumps Market, Strategic Analysis of the Eastern European Pumps Market, and Strategic Analysis of the Pumps Market in the European Oil and Gas Industry. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.

Strategic Analysis of Pumps Market in the European Pharmaceutical Industry / M5A1-10

Twitter: twitter.com/frost_sullivan or facebook.com/FrostandSullivan

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Energy-efficiency Concerns Drive the Total Pumps Market in the European Pharmaceutical Industry Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Joanna Lewandowska 
+48 22 390 41 46 joanna.lewandowska[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)